Jiangsu Hengrui Me. traded at 40.15 this Wednesday July 6th, decreasing 0.36 or 0.89 percent since the previous trading session. Looking back, over the last four weeks, Jiangsu Hengrui Me. lost 31.51 percent. Over the last 12 months, its price fell by 35.30 percent. Looking ahead, we forecast Jiangsu Hengrui Me. to be priced at 37.69 by the end of this quarter and at 34.53 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
40.15
Daily Change
-0.89%
Yearly
-35.30%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Cspc Pharmaceutical 8.17 0.07 0.86% -21.29%
Sino Biopharmaceutical Ltd 5.20 -0.03 -0.57% -26.97%
Sh Fosun Pharma 47.96 0.23 0.48% -26.78%
Sh Pharmaceutical 18.04 -0.22 -1.20% -11.13%
WuXi AppTec Co Ltd 114.43 0.95 0.84% -21.64%

Indexes Price Day Year
SHANGHAI 3362 -41.91 -1.23% -5.39%
SHANGHAI 50 3006 -45.86 -1.50% -12.21%

Jiangsu Hengrui Me.
Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.